While most circulating CLL and MCL cells are characterized by their dependence to BCL-2 for survival, MM and other mature B-cell malignancies are heterogeneous diseases regarding anti-apoptotic protein dependence for survival. The gene discussed is BCL2; the disease is B-cell chronic lymphocytic leukemia.